Four Major Factors Regulate Phosphatidylinositol 3-kinase Signaling Pathway in Cancers Induced by Infection of Human Papillomaviruses

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|26|3057-3069

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.26, 2014-09, pp. : 3057-3069

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery

By Maira Sauveur-Michel   Voliva Charles   Garcia-Echeverria Carlos  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 223-238

Informa Healthcare

Access to resources Recommend Favorite

Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

By Fujino H.   Regan J.W.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 335-340

Elsevier

Access to resources Recommend Favorite

The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils

By Niggli V.   Keller H.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

By Evangelisti Camilla  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 921-936

Informa Healthcare

Access to resources Recommend Favorite